U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353060) titled 'Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT)' on Jan. 13.
Brief Summary: Dupuytren's disease is characterized by retractile fibrosis of the superficial palmar aponeurosis, which can lead to irreversible flexion contractures of the fingers and lasting functional impairment. Widespread throughout the world, it has a particularly high prevalence in northern European countries. This has been estimated at between 3.5% and 11% in England and Denmark. This prevalence is expected to increase over time due to the aging population. Risk factors for the disease include age, male sex, heredity, diabetes, smoking, and alco...